Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused - Endpoints News

Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused - Endpoints News
Business

Listen to this article

0%

Three paΒ­tients died in NoΒ­varΒ­tis triΒ­als of its CD19-diΒ­rectΒ­ed CAR-T treatΒ­ment folΒ­lowΒ­ing a danΒ­gerΒ­ous imΒ­mune sysΒ­tem reΒ­sponse, and a simΒ­iΒ­lar therΒ­aΒ­py from BrisΒ­tol MyΒ­ers Squibb

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected